Photo of Chien-Te Tseng

View Scopus Profile

Chien-Te Tseng, PhD, MS

  • 2520 Citations
  • 30 h-Index
1985 …2021

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Chien-Te Tseng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Efficacy of a leading drug against MERS-CoV infection in vivo

Tseng, C.

3/1/20 → 2/28/21

Project: Other project

Development of Single-Round, Recombinant Vesicular Stomatitis Virus (vsv)-Based Vaccines Against MERS-CoV Infection

Tseng, C.

King Abdulaziz University

9/1/18 → 8/31/21

Project: Other project

Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV

Tseng, C.

University of N Carolina at Chapel Hill

8/9/17 → 7/31/20

Project: Other project

Immunogenicity and efficacy of synthetic virus-mimetic nanoparticle-based MERS vaccine

Tseng, C.

Academia Sinica Taiwan

12/1/17 → 11/30/18

Project: Other project

Subcontract to RBD Recombinant Protein-based SARS Vaccine for Biodefense Preparedness Due to New DOC ID a new CON was created for Yr5.

Tseng, C.

BAYLOR COLLEGE OF MEDICINE

5/1/16 → 7/31/17

Project: Other project

Research Output

  • 2520 Citations
  • 30 h-Index
  • 64 Article
  • 1 Chapter
  • 1 Comment/debate
  • 1 Editorial

Quantification of the middle east respiratory syndrome-coronavirus rna in tissues by quantitative real-time RT-PCR

Algaissi, A., Agrawal, A. S., Hashem, A. M. & Tseng, C. T. K., Jan 1 2020, Methods in Molecular Biology. Humana Press Inc., p. 99-106 8 p. (Methods in Molecular Biology; vol. 2099).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

    • 1 Scopus citations

    A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model

    Hashem, A. M., Algaissi, A., Agrawal, A. S., Al-Amri, S. S., Alhabbab, R. Y., Sohrab, S. S., Almasoud, A. S., Alharbi, N. K., Peng, B. H., Russell, M., Li, X. & Tseng, C. T. K., Oct 8 2019, In : Journal of Infectious Diseases. 220, 10, p. 1558-1567 10 p.

    Research output: Contribution to journal › Article

    • 9 Scopus citations

    A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

    Xia, S., Yan, L., Xu, W., Agrawal, A. S., Algaissi, A., Tseng, C. T. K., Wang, Q., Du, L., Tan, W., Wilson, I. A., Jiang, S., Yang, B. & Lu, L., Jan 1 2019, In : Science Advances. 5, 4, eaav4580.

    Research output: Contribution to journal › Article

    Open Access
    • 19 Scopus citations

    Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease

    Algaissi, A., Agrawal, A. S., Han, S., Peng, B., Luo, C., Li, F., Chan, T. S., Couch, R. B. & Tseng, C-T., Feb 15 2019, In : Journal of Infectious Diseases. 219, 5, p. 829-835 7 p.

    Research output: Contribution to journal › Article

    • 5 Scopus citations

    Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus

    Lin, L. C. W., Huang, C. Y., Yao, B. Y., Lin, J. C., Agrawal, A., Algaissi, A., Peng, B. H., Liu, Y. H., Huang, P. H., Juang, R. H., Chang, Y. C., Tseng, C. T., Chen, H. W. & Hu, C. M. J., Jul 11 2019, In : Advanced Functional Materials. 29, 28, 1807616.

    Research output: Contribution to journal › Article

    • 2 Scopus citations